Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer release version. This appears to be a metadata update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:37:58.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed system revision updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without changing the study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:12:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:39:51.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed on the page. This appears to be an administrative version update that does not modify the study details.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:01.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. No substantive changes to study content or eligibility criteria are indicated.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:33.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed a government funding lapse notice alongside the prior Revision: v3.4.1; these are site maintenance/version updates and do not affect study content, eligibility criteria, or results pages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:35:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.